Human gut flora-fermented nondigestible fraction from cooked bean (phaseolus vulgaris l.) modifies protein expression associated with apoptosis, cell cycle arrest, and proliferation in human adenocarcinoma colon cancer cells

Journal of Agricultural and Food Chemistry

Volumn 60, Issue 51, 2012, Pages 12443-12450

  Campos Vega, Rocio ^a   García Gasca, Teresa ^b   Guevara Gonzalez, Ramón ^a   Ramos Gomez, Minerva ^a   Oomah, B Dave ^c   Loarca Piña, Guadalupe ^a  

^a Queretaro State University   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE QUERÉTARO   (Mexico)

^c SUMMERLAND RESEARCH AND DEVELOPMENT CENTRE   (Canada)

Author keywords

colon cancer; common bean; in vitro fermentation; nondigestible fraction; protein modulation

Indexed keywords

BACTERIAL SOURCE; CELL-CYCLE ARREST; COLON CANCER; COLON CANCER CELLS; COLORECTAL TUMORS; COMMON BEANS; FERMENTATION PRODUCTS; HUMAN ADENOCARCINOMA; HUMAN GUTS; IN-VITRO; MORPHOLOGICAL CHANGES; NONDIGESTIBLE FRACTION; PHASEOLUS VULGARIS; PROTEIN EXPRESSIONS; SHORT-CHAIN FATTY ACIDS;

DISEASES; FERMENTATION; GENE EXPRESSION; PROTEINS;

CELL DEATH;

ANTINEOPLASTIC AGENT; VOLATILE FATTY ACID;

APOPTOSIS; ARTICLE; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CELL STRAIN HT29; CHEMISTRY; COLON; COLON TUMOR; DRUG EFFECT; FERMENTATION; GENE EXPRESSION; GENETICS; HEAT; HUMAN; METABOLISM; MICROBIOLOGY; NICK END LABELING; PH; PHASEOLUS; PLANT SEED;

ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; COLON; COLONIC NEOPLASMS; FATTY ACIDS, VOLATILE; FERMENTATION; GENE EXPRESSION; HOT TEMPERATURE; HT29 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; IN SITU NICK-END LABELING; PHASEOLUS; SEEDS;

BACTERIA (MICROORGANISMS); PHASEOLUS VULGARIS;

EID: 84871551543     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf303940r     Document Type: Article

References (55)

1. Agurs-Collins, T.; Smoot, D.; Afful, J.; Makambi, K.; Adams-Campbell, L. Legume intake and reduced colorectal adenoma risk in African-Americans J. Natl. Black Nurses Assoc. 2006, 17, 6-12
2. Beninger, C. W.; Hosfield, G. L. Antioxidant activity of extracts, condensed tannin fractions, and pure flavonoids from Phaseolus vulgaris L. seed coat color genotypes J. Agric. Food Chem. 2003, 51, 7879-7883
3. Macfarlane, G. T.; Macfarlane, S. Fermentation in the human large intestine: Its physiologic consequences and the potential contribution of prebiotics J. Clin. Gastroenterol. 2011, 45, S120-S127
4. Hoover, R.; Zhou, Y. In vitro and in vivo hydrolysis of legume starches by α-amylase and resistant starch formation in legumes - A review Carbohydr. Polym. 2003, 54, 401-417
5. Canani, R. B.; Costanzo, M. D.; Leone, L.; Pedata, M.; Meli, R.; Calignano, A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases World J. Gastroenterol. 2011, 17 (12) 1519-1528
6. Campos-Vega, R.; Guevara-Gonzalez, R. G.; Guevara-Olvera, B. L.; Oomah, B. D.; Loarca-Piña, G. Bean (Phaseolus vulgaris L.) polysaccharides modulate gene expression in human colon cancer cells (HT-29) Food Res. Int. 2010, 43, 1057-1064
7. Fung, K. Y. C.; Lewanowitsch, T.; Henderson, S. T.; Priebe, I.; Hoffmann, P.; McColl, S. R.; Lockett, T.; Head, R.; Cosgrove, L. J. Proteomic analysis of butyrate effects and loss of butyrate sensitivity in HT29 colorectal cancer cells J. Proteome Res. 2009, 8, 220-1227
8. Henningsson, A. M.; Nyman, E. M.; Bjorck, I. M. Content of short-chain fatty acids in the hindgut of rats fed processed bean (Phaseolus vulgaris) flours varying in distribution and content of indigestible carbohydrates Br. J. Nutr. 2001, 86 (3) 379-389 (Pubitemid 32916195)
9. Wong, J. Colonic health: fermentation and short chain fatty acids J. Clin. Gastroenterol. 2006, 40, 235-243 (Pubitemid 44309560)
10. 1 J. Food Sci. 2005, 70, S73-S78
11. Association of Official Analytical Chemists. Official Methods of Analysis, 17 th ed.; AOAC: Arlington, VA, 2002.
12. Macfarlane, G. T.; Macfarlane, S. Models for intestinal fermentation: association between food components, delivery systems, bioavailability and functional interactions in the gut Curr. Opin. Biotechnol. 2007, 18, 156-162
13. McBurney, M. I.; Thompson, L. U. Effect of human inoculum on in vitro fermentation variables Br. J. Nutr. 1987, 58, 233-243 (Pubitemid 18020754)
14. Campos-Vega, R.; Reynoso-Camacho, R.; Pedraza-Aboytes, G.; Acosta-Gallegos, J. A.; Guzman-Maldonado, S. H.; Paredes-Lopez, O.; Oomah, B. D.; Loarca-Piña, G. Chemical composition and in vitro polysaccharide fermentation of different beans (Phaseolus vulgaris L.) J. Food Sci. 2009, 74 (7) T59-T65
15. Fogh, J.; Trempe, X. Human Tumor Cells in Vitro: Plenum Press: New York, 1975; pp 115-15.
16. Decker, T.; Lohmann-Matthes, M. L. A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity J. Immunol. Methods 1998, 115, 61-69
17. Ben-Sasson, S. A.; Sherman, Y.; Gavrieli, Y. Identification of dying cells-in situ staining Methods Cell Biol. 1995, 46, 29-39
18. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 1976, 72, 248-254
19. Box, G. E. P.; Hunter, W. G.; Hunter, J. S. Statistics for Experimenters; Wiley: New York, 1978.
20. Bown, R. L.; Gibson, J. A.; Sladen, G. E.; Hicks, B.; Dawson, A. M. Effects of lactulose and other laxatives on ileal and colonic pH measured by a radiotelemetry device Gut 1974, 15, 999-1004
21. Walker, W.; Duncan, H. S.; Leitch, McW. C. E.; Child, W. M.; Flint, J. H. pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon Appl. Environ. Microbiol. 2005, 71 (7) 3692-3700
22. Cummings, J. H.; Macfarlane, G. T. Role of intestinal bacteria in nutrient metabolism (JPEN) J. Parenter. Enteral. Nutr. 1997, 21, 357-365
23. Duncan, S. H.; Louis, P.; Flint, H. J. Lactate-utilizing bacteria, isolated from human feces that produce butyrate as a major fermentation product Appl. Environ. Microbiol. 2004, 70 (10) 5810-5817 (Pubitemid 39471821)
24. Sunvold, G. D.; Hussein, H. S.; Fahey, G. C.; Merchen, N. R.; Reinhart, G. A. In vitro fermentation of cellulose, beet pulp, citrus pulp, and citrus pectin using fecal inoculum from cats, dogs, horses, humans, and pigs and ruminal fluid from cattle J. Anim. Sci. 1995, 73, 3639-3648
25. Younes, H.; Coudray, C.; Bellanger, J.; Demigné, C.; Rayssiguier, Y.; Rémésy, C. Effects two fermentable carbohydrates (inulin and resistant starch) and their combination on calcium and magnesium balance in rats Br. J. Nutr. 2001, 86, 479
26. Aune, D.; Chan, D. S.; Lau, R.; Vieira, R.; Greenwood, D. C.; Kampman, E.; Norat, T. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies BMJ 2011, 10, 343
27. Hamer, H. M.; Jonkers, D.; Venema, K.; Vanhoutvin, S.; Troost, F. J.; Brummer, R. J. The role of butyrate on colonic function Aliment. Pharmacol. Ther. 2008, 27, 104-119
28. Beyer-Sehlmeyer, G.; Glei, M.; Hartmann, E.; Hughes, R.; Persin, C.; Böhm, V.; Rowland, I.; Schubert, R.; Jahreis, G.; Pool-Zobel, B. L. Butyrate is only one of several growth inhibitors produced during gut flora-mediated fermentation of dietary fiber sources Br. J. Nutr. 2003, 90, 1057-1070 (Pubitemid 37548038)
29. World Cancer Research Fund and American Institute for Cancer Research. Food, Nutrition and the Prevention of Cancer: A Global Perspective; American Institute for Cancer Research: Washington, DC, 1997.
30. Mariadason, J. M.; Velchich, A.; Wilson, A. J.; Augenlicht, L. H.; Gibson, P. R. Resistance to butyrate-induced cell differentiation and apoptosis during spontaneous Caco-2 cell differentiation Gastroenterology 2001, 120, 889-899 (Pubitemid 32193186)
31. Borowicki, A.; Stein, K.; Scharlau, D.; Scheu, K.; Brenner-Weiss, G.; Obst, U.; Hollmann, J.; Lindhauer, M.; Wachter, N.; Glei, M. Fermented wheat aleurone inhibits growth and induces apoptosis in human HT29 colon adenocarcinoma cells Br. J. Nutr. 2010, 103 (3) 360-369
32. Ruemmele, F. M.; Schwartz, S.; Seidman, G. E.; Dionea, S.; Lentze, E. L.; Lentze, M. J. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway Gut 2003, 52, 94-100 (Pubitemid 36020773)
33. Lacour, S.; Micheau, O.; Hammann, A.; Drouineaud, V.; Tschopp, J.; Solary, E.; Dimanche-Boitrel, M. T. Chemotherapy enhances TNF-related apoptosis-inducing ligand DISC assembly in HT29 human colon cancer cells Oncogene 2003, 22 (12) 1807-1816 (Pubitemid 36519144)
34. Pattingre, S.; Tassa, A.; Qu, X.; Garuti, R.; Liang, X. H.; Mizushima, N.; Packer, M.; Schneider, M. D.; Levine, B. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy Cell 2005, 122 (6) 927-939 (Pubitemid 41345209)
35. Culotta, E.; Koshland, D. E. p53 sweeps through cancer research Science 1993, 262, 1958-1961 (Pubitemid 24041868)
36. Rodriguez, N. R.; Rowan, A.; Smith, M. E.; Kerr, I. B.; Bodmer, W. F.; Gannon, J. V.; Lane, D. P. p53 mutations in colorectal cancer Proc. Natl. Acad. Sci. U.S.A. 1990, 87, 7555-7559 (Pubitemid 20341755)
37. Toledo, F.; Geoffrey, M.; Wahl, G. M. MDM2 and MDM4: p53 regulators as targets in anticancer therapy Int. J. Biochem. Cell Biol. 2007, 39 (7-8) 1476-1482 (Pubitemid 47031042)
38. Tian, Y.; Song, Y. Effects of inositol hexaphosphate on proliferation of HT-29 human colon carcinoma cell line World J. Gastroenterol. 2006, 12 (26) 4137-4142 (Pubitemid 44376889)
39. Tenderenda, M. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes J. Exp. Clin. Cancer. Res. 2005, 24, 405-414 (Pubitemid 41416125)
40. Grösch, S.; Tegeder, I.; Niederberger, E.; Bräutigam, L.; Geisslinger, G. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib FASEB J. 2001, 15, 2742-2744
41. Kles, K.; Chang, E. Short-chain fatty acids impact on intestinal adaptation, inflammation, carcinoma, and failure Gastroenterology 2006, 130 (2) S100-S105
42. Mundle, S. D.; Saberwal, G. Evolving entricacies and implications of E2F1 regulation FASEB J 2003, 17 (6) 569-574 (Pubitemid 37221141)
43. Zheng, Q. H.; Ma, L. W.; Zhu, W. G.; Zhang, Z. Y.; Tong, T. J. p21(Waf1/Cip1) plays a critical role in modulating senescence through changes of DNA methylation J. Cell Biochem. 2006, 98 (5) 1230-1248 (Pubitemid 44128362)
44. Poulogiannis, G.; Frayling, I. M.; Arends, M. J. DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome Histopathology 2010, 56, 167-179
45. Coxhead, J. M.; Williams, E. A.; Mathers, J. C. DNA mismatch repair status may influence anti-neoplastic effects of butyrate Biochem. Soc. Trans. 2005, 33, 728-729 (Pubitemid 41160851)
46. Inan, M. S.; Rasoulpour, R. J.; Yin, L.; Hubbard, R. K.; Rosenberg, D. W.; Giardina, C. The luminal short-chain fatty acid butyrate modulates NFκB activity in a human colonic epithelial cell line Gastroenterology 2000, 118, 724-734 (Pubitemid 30171622)
47. Kikuchi, E.; Horiguchi, Y.; Nakashima, J.; Kuroda, K.; Oya, M.; Ohigashi, T.; Takahashi, N.; Shima, Y.; Umezawa, K.; Murai, M. Suppression of hormone-refractory prostate cancer by a novel nuclear factor B inhibitor in nude mice Cancer Res. 2003, 63, 107-110 (Pubitemid 36070427)
48. Izzo, J. G.; Malhotra, U.; Wu, T. T.; Ensor, J.; Luthra, R.; Lee, J. H.; Swisher, S. G.; Liao, Z.; Chao, K. S.; Hittelman, W. N.; Aggarwal, B. B.; Ajani, J. A. Association of activated factor nuclear factor κB with chemoradiation resistance and poor outcome in esophageal carcinoma J. Clin. Oncol. 2006, 24, 748-754 (Pubitemid 46622041)
49. Tedelin, S.; Westberg, F.; Kjerrulf, M.; Vidal, A. Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease World J. Gastroenterol. 2007, 13, 2826-2832 (Pubitemid 47007897)
50. Hodin, R. Maintaining gut homeostasis: the butyrate-NF-κB connection Gastroenterology 2000, 118 (4) 798-801 (Pubitemid 30171630)
51. Baldwin, A. S. Control of oncogenesis and cancer therapy resistance by the transcription factor NF-κB J. Clin. Invest 2001, 107 (3) 241-246 (Pubitemid 32157954)
52. Weichert, W.; Röske, A.; Niesporek, S.; Noske, A.; Buckendah, A. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo Clin. Cancer Res. 2008, 14, 1669-1677 (Pubitemid 351469450)
53. Hinnebusch, B. F.; Meng, S.; Wu, J. T.; Archer, S. Y.; Hodin, R. A. The effects of short-chain fatty acids on human colon cancer cell phenotype are associated with histone hyperacetylation J. Nutr. 2002, 132, 1012-1017 (Pubitemid 34493567)
54. Iacomino, G.; Tecce, M. F.; Grimaldi, C.; Tosto, M.; Russo, G. L. Transcriptional response of a human colon adenocarcinoma cell line to sodium butyrate Biochem. Biophys. Res. Commun. 2001, 285, 1280-1289 (Pubitemid 32912922)
55. Corfe, B. M. Hypothesis: butyrate is not an HDAC inhibitor, but a product inhibitor of deacetylation Mol. Biol. Syst. 2012, 8, 1609-1612